Compounds

Details for Australian Patent Application No. 2009211251 (hide)

Owner Pulmagen Therapeutics (Synergy) Limited AstraZeneca AB

Inventors Johnson, Timoty; Tobald, Barry John; Bailey, Andrew; Alcaraz, Lilian; Lister, Andrew Stuart; Robbins, Andrew James; Stocks, Michael John; Bull, Richard James; Kindon, Nicholas David

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2009211251

PCT Pub. Number WO2009/098448

Priority 0802192.5 06.02.08 GB; 0822437.O 09.12.08 GB

Filing date 4 February 2009

Wipo publication date 13 August 2009

Acceptance publication date 2 February 2012

International Classifications

C07D 498/10 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/098448 Priority application(s): WO2009/098448

2 February 2012 Application Accepted

  Published as AU-B-2009211251

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009211253-Methods and compositions

2009211249-Masonry with vertical reinforced concrete strengthening